INFORMATION BY CANCER TYPE
More personalized approaches are being developed to treat patients with metastatic disease.
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.
From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.
Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.
A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.
States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.
NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.
Finding specialized care is worth the effort for patients with uncommon cancers.
Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Anal Cancer Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of anal cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Anal Cancer Prevention (PDQ®)
[ Patients ]
Expert-reviewed information summary about factors that may influence the risk of developing anal cancer and about research aimed at the prevention of this disease.